![Michael D. Grisham](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael D. Grisham
Founder at Curate Biosciences
Michael D. Grisham active positions
Companies | Position | Start | End |
---|---|---|---|
Curate Biosciences
![]() Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | Founder | 2001-12-31 | - |
Chairman | 2022-12-15 | - | |
Chief Executive Officer | 2001-12-31 | 2022-12-15 |
Career history of Michael D. Grisham
Former positions of Michael D. Grisham
Companies | Position | Start | End |
---|---|---|---|
Cellective Dx Corp.
![]() Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Founder | 2009-10-14 | 2009-11-02 |
President | 2004-12-31 | 2009-11-02 | |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Chairman | - | - |
Verinata Health, Inc.
![]() Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Founder | - | - |
President | - | - | |
ParadigmHealth, Inc.
![]() ParadigmHealth, Inc. Hospital/Nursing ManagementHealth Services ParadigmHealth, Inc. provides disease management services. The company was founded in 1991 and is headquartered in Upper Saddle River, NJ. | President | - | - |
NeuroCare Group
![]() NeuroCare Group Medical SpecialtiesHealth Technology Part of Integra LifeSciences Holdings Corp., NeuroCare Group is a company that manufactures neurosurgical instruments and monitoring devices. The company is based in Carlsbad, CA. NeuroCare Group was acquired by Integra LifeSciences Holdings Corp. on March 29, 1999 for $14 million. | President | - | - |
Training of Michael D. Grisham
Stanford University | Masters Business Admin |
University of California, Berkeley | Undergraduate Degree |
Statistics
International
United States | 9 |
Operational
President | 4 |
Founder | 3 |
Chairman | 2 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Health Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 6 |
---|---|
Cellective Dx Corp.
![]() Cellective Dx Corp. Pharmaceuticals: GenericHealth Technology Informed decisions will improve the way cancer is treated. On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its platform will enable better decision-making across multiple cancers: improving the cost of treatment, the quality of life for patients and ultimately increasing survival. Products currently in development are based on two core technologies: 1) DNA repair biomarkers that predict treatment response and 2) Microfluidic chip technology that enables capture, enumeration and characterization of circulating tumor cells (CTCs) in the bloodstream. | Health Technology |
NeuroCare Group
![]() NeuroCare Group Medical SpecialtiesHealth Technology Part of Integra LifeSciences Holdings Corp., NeuroCare Group is a company that manufactures neurosurgical instruments and monitoring devices. The company is based in Carlsbad, CA. NeuroCare Group was acquired by Integra LifeSciences Holdings Corp. on March 29, 1999 for $14 million. | Health Technology |
ParadigmHealth, Inc.
![]() ParadigmHealth, Inc. Hospital/Nursing ManagementHealth Services ParadigmHealth, Inc. provides disease management services. The company was founded in 1991 and is headquartered in Upper Saddle River, NJ. | Health Services |
Verinata Health, Inc.
![]() Verinata Health, Inc. Medical/Nursing ServicesHealth Services Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA. | Health Services |
Virginia Biotechnology Association
![]() Virginia Biotechnology Association Miscellaneous Commercial ServicesCommercial Services Virginia Biotechnology Association promotes the biotechnology industry. The private company is based in Richmond, VA. The company was founded in 1992 by Terry R. Woodworth. John L. Newby has been the CEO of the company since 2019. | Commercial Services |
Curate Biosciences
![]() Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Curate Biosciences engages in the development of a liquid biopsy platform for obtaining rare circulating tumor cells. It offers a desktop fluidic system for cell separation that pumps blood through a disposable microchip. The company was founded by Michael D. Grisham in 2002 and is headquartered in Richmond, VA. | Commercial Services |
- Stock Market
- Insiders
- Michael D. Grisham
- Experience